Zilbrysq 32.4MG/0.81ML INJ, soln SY.
Active Awarded Last action
- Contract number
- 36C26026F0046
- Awardee
-
Ucb, Inc. UEI F3N9Q9TY2BC9
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $371,175
Award facts
- Contract value 100% obligated
- $371,175.06 Current and potential, with all options
- Completion date 99% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15205, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $3,949 | |
| Original award | $367,226 |
About this award
On October 25, 2025, the Department of Veterans Affairs, through Veterans Integrated Service Network 20, awarded a delivery order to UCB Pharma, Inc. (Ucb, Inc.) for the supply of Zilbrysq 32.4MG/0.81ML injection solution, including a 2026 price increase adjustment. This firm fixed-price delivery order, valued at $371.2K, is scheduled for completion by October 24, 2026, and operates without a set-aside designation. The award is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), leveraging UCB Pharma's larger Federal Supply Schedule agreement with VISN 12 that carries a $1.11 billion ceiling and extends through September 2030. Zilbrysq is a neurological injectable medication that addresses critical healthcare needs within the VA system for veterans nationwide.
UCB Pharma, a global biopharmaceutical company specializing in neurology and immunology treatments, has established itself as a reliable pharmaceutical supplier to the VA through multiple delivery orders and contract vehicles. This delivery order represents part of the company's ongoing supply relationship with the VA and follows several previous orders for Zilbrysq delivered in 2024 and 2025. All of UCB Pharma's federal contracts with the VA operate under firm fixed-price structures and pre-negotiated pricing established through the Federal Supply Schedule, enabling efficient and cost-effective acquisition of essential prescription medications to support the VA's healthcare mission for the veteran population.
Quick answers
Who was awarded contract 36C26026F0046?
36C26026F0046 was awarded to Ucb, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 25, 2025.
How much is contract 36C26026F0046 worth?
The government has obligated $371,175 on 36C26026F0046.
Is contract 36C26026F0046 an order under another contract?
Yes. 36C26026F0046 is a delivery order under 36F79725D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26026F0046 competed?
The extent of competition for 36C26026F0046 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award